top of page

Q2 2025 warning letter roundup with Asa Waldstein

Asa Waldstein

Q2 2025 warning letter roundup with Asa Waldstein

Guest Article

In his quarterly update, consultant Asa Waldstein identifies trends in FDA warning letters impacting manufacturers and marketers of dietary supplements.

Each quarter, I provide updates on notable FDA warning letters and enforcement trends. Understanding enforcement trends is essential for being a savvy marketer, regulatory affairs professional or dietary supplement executive. Have you wondered why FDA issues warning letters to certain companies and not others? FDA likes to make examples of companies not following the rules in areas they want to focus on, many of which I review here. Staying ahead of trouble is one of the critical and fun reasons to follow enforcement trends.


This warning letter roundup focuses on social media warning letters, unallowable ingredients and a CBD update. I hope you enjoy it!

AHPA-member-logo.png
  • LinkedIn
  • YouTube
  • Facebook

American Herbal Products Association (AHPA) Member

©2024 by Supplement Advisory Group LLC. All Rights Reserved

Disclaimer: The educational information provided on this website is for informational purposes only. Contact an attorney for specific legal advice.  Rule #1 in compliance is to ensure marketing is truthful and not misleading.

​

Privacy Policy. |. Terms of Use. |. Sitemap

bottom of page